UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts

Company Overview - UnitedHealth Group (UNH) closed at $492.11, reflecting a +0.57% change from the previous trading day's close, outperforming the S&P 500's daily gain of 0.07% [1] - Over the past month, shares have depreciated by 1.14%, outperforming the Medical sector's loss of 1.99% but lagging behind the S&P 500's gain of 4.34% [1] Upcoming Earnings - The upcoming earnings report is scheduled for July 16, 2024, with projected earnings of$ 6.68 per share, indicating year-over-year growth of 8.79% [1] - Quarterly revenue is expected to be $98.95 billion, up 6.51% from the same period last year [1] Full Year Estimates - For the full year, earnings are projected at$ 27.55 per share and revenue at $398.24 billion, reflecting changes of +9.67% and +7.16% respectively from the previous year [2] Analyst Estimates and Stock Performance - Recent modifications to analyst estimates indicate a favorable outlook on the company's business health and profitability [2] - The Zacks Rank system currently rates UnitedHealth Group at 3 (Hold), with the consensus EPS estimate moving 0.09% lower over the last 30 days [3] Valuation Metrics - UnitedHealth Group has a Forward P/E ratio of 17.76, which is a premium compared to the industry's average Forward P/E of 17.13 [3] - The company has a PEG ratio of 1.44, compared to the Medical - HMOs industry's average PEG ratio of 1.22 [3] Industry Context - The Medical - HMOs industry is ranked 204 in the Zacks Industry Rank, placing it in the bottom 20% of over 250 industries [4] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]